Why Hims & Hers Health, Inc. (HIMS) stock moved
Hims & Hers Health, Inc. (HIMS) shares climbed 10.2% to $30.92 as of October 9, 2026, a sharp gain from the prior close of $28.06. BestStocks flagged the session as a major change for HIMS. Below, we break down what changed for HIMS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
HIMS climbed 10.2% to $30.92
Hims & Hers reversed a prior-session decline, gaining 6.54% to $29.89 intraday. The bounce follows yesterday's 5.01% drop (Zacks, 2026-10-08), though no fresh catalyst emerged today; the rebound may reflect technical oversold conditions or short-covering after recent weakness. Volume remains at 1.0x normal for this session time. HIMS earnings on November 2, 2026 (date pending confirmation); consensus EPS estimate is $0.12. Monitor for any updates on FDA regulatory status or margin trends.
What it means for Hims & Hers Health, Inc. investors
For Hims & Hers Health, Inc. investors, the balance of recent signals points to a bullish shift. On the constructive side: Strong 10.2% price move; Positive price momentum. Weighing against that: Hims & Hers declined 6.38% to $27.66 amid ongoing securities class action litigation and personnel changes; Hims & Hers Health (HIMS) declined 6.41% to $29.63 intraday, cited by Google's AI Overview as linked to content on finance.yahoo.com covering the stock's move on 2026-08-28. Wall Street's consensus price target sits at $32.17, implying +4.0% upside from $30.92. BestStocks rates the overall signal quality medium (60/100). With earnings roughly 31 days out, the next report is the most likely near-term test of the move.
HIMS price reaction
HIMS last traded at $30.92, up $2.86 (+10.19%) from the previous close of $28.06. The session traded on 1.2× average volume (normal), so participation was unremarkable.
Bullish and bearish analyst opinions on Hims & Hers Health, Inc. (HIMS)
The consensus analyst price target on Hims & Hers Health, Inc. (HIMS) is $32.17, 4.0% above the recent $30.92. Over the past 90 days analysts logged 0 upgrades, 10 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HIMS line up.
The bullish case
- Wall Street's consensus price target of $32.17 implies +4.0% upside from $30.92.
- The Street's most bullish target is $42.00 (+35.8%).
- Strong 10.2% price move.
- Positive price momentum.
The bearish case
- The most bearish analyst target is $24.50 (-20.8%).
- Hims & Hers declined 6.38% to $27.66 amid ongoing securities class action litigation and personnel changes.
- Hims & Hers Health (HIMS) declined 6.41% to $29.63 intraday, cited by Google's AI Overview as linked to content on finance.yahoo.com covering the stock's move on 2026-08-28.
- Hims & Hers shares fell 6.05% to $29.83, continuing a sharp year-to-date decline of 15.9% (per Yahoo Finance, Apr 29, 2026).
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 9, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for HIMS
In-depth HIMS event analyses
Frequently asked questions about HIMS
Why did Hims & Hers Health, Inc. (HIMS) stock move?
HIMS climbed 10.2% to $30.92. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did HIMS stock rise?
HIMS gained 10.19% ($2.86) versus the prior close of $28.06, last trading at $30.92 on 1.2× average volume.
When is Hims & Hers Health, Inc.'s next earnings date?
HIMS's next earnings report is estimated for 2026-11-09 — about 31 days away.
What is the analyst price target for HIMS?
The consensus analyst price target for HIMS is $32.17, about 4.0% above the current $30.92. Over the past 90 days, analysts recorded 0 upgrades, 10 maintains, and 0 downgrades.
How BestStocks tracks HIMS
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared HIMS-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for HIMS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 9, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.